Jove
Visualize
Contáctanos

Videos de Conceptos Relacionados

Depression: Overview01:18

Depression: Overview

229
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
229
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

59
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
59
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

209
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
209
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

401
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
401
Cognitive Therapy01:25

Cognitive Therapy

148
Cognitive therapy, pioneered by Aaron T. Beck in the 1960s, is a structured approach to addressing psychological distress by focusing on the influence of thoughts on emotions and behaviors. All cognitive therapies involve the basic assumption that human beings have control over their feelings, and that how individuals feel about something depends on how they think about it. Unlike psychoanalytic methods that delve into unconscious processes or humanistic approaches emphasizing...
148
Long-term Depression01:05

Long-term Depression

30.7K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
30.7K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

The Lateral Habenula to Ventral Tegmental Area Pathway is Required for Aversive Learning and Defensive Behaviors.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2026
Same author

Review: "The Disappointment Dilemma: Short- and Long-Term Learning From Negative Outcomes".

The European journal of neuroscience·2026
Same author

Transcriptional Profiling of the Cortico-Accumbal Pathway Reveals Sex-Specific Alterations Underlying Stress Susceptibility.

Biological psychiatry·2025
Same author

Chronic Social Defeat Stress Induces Pathway-Specific Adaptations at Lateral Habenula Neuronal Outputs.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2024
Same author

Hypothalamic neuronal outputs transmit sensorimotor signals at the onset of locomotor initiation.

iScience·2023
Same author

A novel role for the lateral habenula in fear learning.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2022
Same journal

Erratum for the Research Article "Detecting supramolecular organic nanoparticles during heat wave".

Science (New York, N.Y.)·2026
Same journal

Local signals, systemic decline.

Science (New York, N.Y.)·2026
Same journal

The mechanics of liver regeneration.

Science (New York, N.Y.)·2026
Same journal

Computing in a memory with physics.

Science (New York, N.Y.)·2026
Same journal

Retraction.

Science (New York, N.Y.)·2026
Same journal

Making time.

Science (New York, N.Y.)·2026
Ver todos los artículos relacionados
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Video Experimental Relacionado

Updated: Jun 17, 2025

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

28.5K

El bloqueo de la depresión

Jose Cesar Hernandez Silva1, Christophe D Proulx1

  • 1Universite Laval, Quebec City, Quebec, Canada.

Science (New York, N.Y.)
|August 8, 2024
PubMed
Resumen
Este resumen es generado por máquina.

La ketamina, un antidepresivo, trabaja bloqueando los neurorreceptores específicos. Esta acción se dirige a áreas hiperactivas en el cerebro, ofreciendo un nuevo enfoque para el tratamiento de la depresión.

Más Videos Relacionados

Animal Models of Depression - Chronic Despair Model CDM
05:47

Animal Models of Depression - Chronic Despair Model CDM

Published on: September 23, 2021

7.2K
The Forced Swim Test as a Model of Depressive-like Behavior
05:42

The Forced Swim Test as a Model of Depressive-like Behavior

Published on: March 2, 2015

37.2K

Videos de Experimentos Relacionados

Last Updated: Jun 17, 2025

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

28.5K
Animal Models of Depression - Chronic Despair Model CDM
05:47

Animal Models of Depression - Chronic Despair Model CDM

Published on: September 23, 2021

7.2K
The Forced Swim Test as a Model of Depressive-like Behavior
05:42

The Forced Swim Test as a Model of Depressive-like Behavior

Published on: March 2, 2015

37.2K

Área de la Ciencia:

  • La neurociencia
  • Farmacología

Sus antecedentes:

  • La depresión está relacionada con la hiperactividad en ciertas regiones del cerebro.
  • Los antidepresivos existentes tienen limitaciones en la eficacia y los perfiles de efectos secundarios.

Objetivo del estudio:

  • Investigar el mecanismo de acción de la ketamina como antidepresivo.
  • Para identificar los neurorreceptores específicos y las regiones del cerebro afectadas por la ketamina.

Principales métodos:

  • Utilizó técnicas de neuroimagen para observar la actividad cerebral.
  • Administración de ketamina y monitoreo del bloqueo de los neurorreceptores.
  • Los cambios analizados en la actividad neuronal en respuesta a la ketamina.

Principales resultados:

  • Se encontró que la ketamina bloqueaba eficazmente los neurorreceptores.
  • Este bloqueo se concentró en regiones hiperactivas del cerebro asociadas con la depresión.
  • Se observó una reducción de la hiperactividad en áreas específicas del cerebro.

Conclusiones:

  • Los efectos antidepresivos de la ketamina están mediados por el bloqueo de los neurorreceptores en circuitos cerebrales hiperactivos.
  • Este mecanismo ofrece una nueva estrategia terapéutica para la depresión resistente al tratamiento.